Kaliumklorid Noridem

Potassium chloride, the active ingredient in Kaliumklorid Noridem, is an electrolyte / potassium supplement presented as an intravenous solution for intravenous use. It treats hypokalemia and related potassium depletion in patients requiring rapid correction.

GNH USA supplies Kaliumklorid Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kaliumklorid Noridem is used to correct potassium deficits in conditions that affect electrolyte balance.

- Hypokalemia: restores normal serum potassium levels in patients with low potassium. - Potassium depletion due to diuretic therapy: replaces potassium lost from chronic diuretic use. - Prevention of cardiac arrhythmias related to low potassium: helps maintain cardiac electrophysiology and reduces arrhythmia risk.

Kaliumklorid Noridem may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Infusion site irritation or pain. - Transient hyperkalemia with mild symptoms. - Nausea or vomiting. - Muscle weakness or cramping. - Paresthesia (tingling sensations). - Mild hypotension.

Serious or Rare Side Effects: - Severe hyperkalemia leading to cardiac arrest. - Life‑threatening arrhythmias. - Anaphylactic or severe allergic reactions. - Venous thrombosis at the infusion site. - Cardiac conduction disturbances. - Acute renal failure secondary to electrolyte imbalance.

Before using Kaliumklorid Noridem, clinicians should consider several safety measures.

- Monitor serum potassium: check levels before, during, and after infusion. - Adjust infusion rate: use a controlled rate to avoid rapid potassium spikes. - Review renal function: reduce dose or avoid if renal impairment is present. - Avoid in existing hyperkalemia: contraindicated when serum potassium is already elevated. - Use ECG monitoring: especially in patients with cardiac disease. - Store below 25°C: keep in the original container, protect from light and moisture.

Kaliumklorid Noridem can interact with other medications that affect potassium balance or cardiac function.

Major Interactions (Avoid): - ACE inhibitors: may cause excessive potassium accumulation. - Angiotensin II receptor blockers (ARBs): increase risk of hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): potentiate potassium rise. - NSAIDs: reduce renal potassium excretion. - Trimethoprim‑sulfamethoxazole: can elevate serum potassium.

Moderate Interactions (Monitor Closely): - Digoxin: heightened risk of digoxin toxicity with high potassium. - Beta‑blockers: may mask symptoms of hyperkalemia. - Insulin: potassium shifts intracellularly; monitor levels. - Glucocorticoids: affect potassium handling. - Lithium: concurrent use may alter lithium levels.